It is quite significant that even with the growing evidence regarding the safe use of ARNIs in this population since 2018, the proportion of patients remains almost the same in different but comparable cohorts [ 36 ].
← all excerpts
Use and Benefit of Sacubitril/Valsartan in Elderly Patients with Heart Failure with Reduced Ejection Fraction.
1
—
—